Pharmaceutical Market Europe • September 2026 • 37
APPOINTMENTS
Lucid Group
Lucid Group has appointed Eric Muller as Chief Executive Officer (CEO). Muller will succeed CEO, and original DiD Agency founder, Rick Sannem.
Muller’s immediate priorities centre on expanding talent, client partnerships as well as data and technological capabilities. He is a highly experienced executive who has operated both commercially and in senior leadership positions across global healthcare commercialisation for more than 25 years. Most recently, Muller was Group President and Chief Operating Officer of Publicis Health and previously held roles including President of Digitas Health. He began his career at Grey Advertising in New York.
Sannem, Strategic Advisor to Lucid’s Board of Directors, said: “Eric’s track record as a hands-on, transformative leader makes him the right person to lead Lucid into its next chapter of growth.”
Envision Pharma Group
Ryan Tubbs
Envision Pharma Group has appointed Ryan Tubbs as Senior Vice President, Commercial Growth. In this newly created role, Tubbs will lead the centralised Commercial Growth function spanning sales enablement, lead generation, marketing and client success. He will also help shape the company’s commercial strategy and operating model to accelerate enterprise growth. Tubbs brings more than two decades of commercial and customer leadership experience across enterprise software, healthcare and life sciences, higher education, and public sector organisations. He most recently served as SVP, Customer Success, Value & Managed Services at Ellucian, leading a global post-sale organisation, driving retention, expansion and margin performance.
VML Health
Sus Misra
VML Health has appointed Sus Misra as Executive Director, Data & Analytics, a new role created to put advanced analytics, AI and health data strategy at the heart of client growth. Misra will lead VML Health’s global data and analytics capability, building the infrastructure, governance and AI powered capabilities to turn complex health data ecosystems into clear commercial outcomes for the agency’s pharma and life sciences clients. With more than 20 years’ experience in health and marketing analytics, Misra has led data and measurement strategy for pharmaceutical and medtech clients across a number of therapeutic areas. Misra joins VML Health from Havas Media, where he served as SVP, Consumer Science & Analytics. Prior to this, he held senior roles at IPG and Publicis.
Saatchi & Saatchi
Pedro Rosa and May Leen Wong
Saatchi & Saatchi Health London has appointed Pedro Rosa as Executive Creative Director and May Leen Wong as Head of Strategy. Rosa joins from a career including VML UK and Brazil, Grey London, Mother and AlmapBBDO. He will lead creative vision and culture across the agency. May Leen Wong joins with more than two decades of global experience spanning consumer, healthcare and wellness brands. She was most recently EVP, Executive Strategy Director at Havas Health. Rosa and Wong will be responsible for partnering closely with clients and teams. They will both report directly to Katie McMorran, Group Managing Director, who said: “Pedro and May both bring international experience, outstanding track records and a relentless belief in the power of creativity.”